The settlement mostly concludes Louisiana Attorney General Buddy Caldwell’s three-year fight against unfair drug pricing in the state’s Medicaid program, according to a Times-Picayune report. Since 2010, Louisiana has recovered more than $238 million from more than 100 drug companies over pricing practices.
“These companies took advantage of the state and its taxpayers by fraudulently over-pricing and marketing prescription drugs, thereby forcing the state’s Medicaid program to grossly over-pay for those prescriptions,” Mr. Caldwell told KSLA. He said the recovered funds, 25 to 50 percent of which will be kept by the state, will go back into the Medicaid program to help Louisiana’s most needy patients.
More Articles on Healthcare Lawsuits:
Ascension Health Sees Whistle-Blower False Claims Act Suit Dismissed
Baptist Health Systems Settles FCA Suit With $3.7M
Brownsville Doctors Hospital Faces $2M Suit From Creditor
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.